Back to top

Ironwood Pharma (IRWD) Receives a Rating Update from a Top Analyst

In a report released yesterday, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Ironwood Pharma. The company’s shares closed today...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Ironwood Pharmaceuticals, Inc. (IRWD)